Detalhe da pesquisa
1.
Acute coronary syndromes.
Lancet
; 399(10332): 1347-1358, 2022 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367005
2.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587659
3.
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option.
Int J Mol Sci
; 24(1)2022 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36613613
4.
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
Diabetologia
; 64(6): 1226-1234, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611623
5.
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
N Engl J Med
; 374(12): 1134-44, 2016 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26934567
6.
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.
Circ Res
; 121(1): 81-88, 2017 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506971
7.
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
Circulation
; 134(4): 304-13, 2016 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27440003
8.
Inactivating mutations in NPC1L1 and protection from coronary heart disease.
N Engl J Med
; 371(22): 2072-82, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25390462
9.
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease.
JAMA
; 317(9): 937-946, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267856
10.
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease.
Haematologica
; 105(7): e365-e369, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699787
11.
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
Eur J Prev Cardiol
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788773
12.
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.
Lancet
; 380(9850): 1317-24, 2012 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22932716
13.
Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study Protocol.
High Blood Press Cardiovasc Prev
; 30(6): 573-583, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030852
14.
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT).
Atherosclerosis
; 366: 32-39, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696749
15.
A quantitative-PCR protocol rapidly detects αGAL deletions/duplications in patients with Anderson-Fabry disease.
Mol Genet Metab
; 105(4): 687-9, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22341397
16.
Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
Int J Cardiol
; 354: 7-13, 2022 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176406
17.
Sex-Related Differences in Long-Term Outcomes After Early-Onset Myocardial Infarction.
Front Cardiovasc Med
; 9: 863811, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859592
18.
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Circulation
; 121(16): 1809-17, 2010 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385930
19.
Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study.
Eur Heart J
; 30(17): 2095-101, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19508994
20.
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO Trial.
J Am Coll Cardiol
; 71(17): 1869-1877, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540324